Medicare Will Start Covering Weight-Loss Drugs on July 1 for the First Time

Medicare patients can get GLP-1s as of July 1

Medicare beneficiaries for the first time will be eligible for coverage of breakthrough GLP-1 weight-loss medications after years of struggling to get the drugs to more seniors. Starting July 1, eligible patients can get GLP-1s to treat obesity for just $50 per month as part of a test program for Medicare, the social safety net health insurance program for seniors over age 65. Medicare Part D, the prescription drug benefit program, already cover…

Medicare will start covering weight-loss drugs on July 1 for the first time

Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program that launches July 1.

Medicare Starts Covering Obesity Drugs July 1 — A Massive Catalyst for Novo Nordisk and Eli Lilly

Starting Wednesday, July 1, Medicare will cover GLP-1 obesity drugs for the first time in the program’s history — a watershed development that could unlock millions of new patients for Novo Nordisk (NVO) and Eli Lilly (LLY). Eligible beneficiaries can access weight-loss drugs like Wegovy and Zepbound for a flat $50 monthly copay under Medicare’s new Bridge demonstration program, dramatically undercutting the out-of-pocket prices patients current…